BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22867129)

  • 21. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019.
    Tofighi B; Lekas HM; Williams SZ; Martino D; Blau C; Lewis CF
    J Subst Abuse Treat; 2021 Oct; 129():108372. PubMed ID: 34080543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National survey identifying community pharmacist preceptors' experience, knowledge, attitudes, and behaviors influencing intent to recommend cannabidiol products.
    Nichols MA; Arnett SJ; Fa B; Marchionda RA; Cutting MC; McDonald MR; Miller ML
    J Am Pharm Assoc (2003); 2021; 61(4S):S91-S104. PubMed ID: 33558186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.
    Linas BP; Coffin PO; Backes G; Vlahov D
    J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National assessment of pharmacist awareness of loperamide abuse and ability to restrict sale if abuse is suspected.
    Feldman R; Everton E
    J Am Pharm Assoc (2003); 2020; 60(6):868-873. PubMed ID: 32641253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of smoking cessation-related activities by pharmacists.
    Williams DM; Newsom JF; Brock TP
    J Am Pharm Assoc (Wash); 2000; 40(3):366-70. PubMed ID: 10853537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge, attitude and practice of community pharmacists towards nutrition counseling.
    Medhat M; Sabry N; Ashoush N
    Int J Clin Pharm; 2020 Dec; 42(6):1456-1468. PubMed ID: 32860597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacists' perceptions of participation in a community pharmacy-based nicotine replacement therapy distribution program.
    Hoch MA; Hudmon KS; Lee L; Cupp R; Aragon L; Tyree RA; Corelli RL
    J Community Health; 2012 Aug; 37(4):848-54. PubMed ID: 22143162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff.
    Iyer P; McFarland R; La Caze A
    Int J Pharm Pract; 2017 Aug; 25(4):292-300. PubMed ID: 27633447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey.
    Klein SJ; Harris-Valente K; Candelas AR; Radigan M; Narcisse-Pean M; Tesoriero JM; Birkhead GS
    J Urban Health; 2001 Dec; 78(4):679-89. PubMed ID: 11796814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacists' attitudes and practices about selling syringes to people who inject drugs in Tajikistan: Results of a syringe purchase audit and a survey.
    Ibragimov U; Haardörfer R; Cooper HLF; Dunkle KL; Zule WA; Wong FY
    Int J Drug Policy; 2019 Sep; 71():62-72. PubMed ID: 31226505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacists' Perceptions of Tobacco Sales in an Elevated-Risk Population.
    Kelly KM; Agarwal P; Attarabeen O; Scott VG; Elswick B; Dolly B; Tworek C
    J Pharm Technol; 2015 Oct; 31(5):195-203. PubMed ID: 34860921
    [No Abstract]   [Full Text] [Related]  

  • 36. Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City.
    Crawford ND; Blaney S; Amesty S; Rivera AV; Turner AK; Ompad DC; Fuller CM
    J Urban Health; 2011 Feb; 88(1):176-85. PubMed ID: 21279450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacists' role in smoking cessation activities in Alsace].
    Le Louarn A; Gérard S
    Sante Publique; 2002 Jun; 14(2):121-34. PubMed ID: 12375518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacists' knowledge and interest in developing counseling skills relating to oral contraceptives.
    Amin ME
    Int J Clin Pharm; 2016 Apr; 38(2):395-403. PubMed ID: 26873480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives and perceived barriers to pharmacist-prescribed tobacco cessation services in the community pharmacy setting.
    Xiong S; Willis R; Lalama J; Farinha T; Hamper J
    J Am Pharm Assoc (2003); 2021; 61(4S):S39-S48. PubMed ID: 33483273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the quality of smoking cessation in community pharmacies: A simulated patient study.
    Alzubaidi H; Austin Z; Saidawi W; Rees VW
    Res Social Adm Pharm; 2022 Jun; 18(6):2997-3003. PubMed ID: 34284972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.